ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Timber Pharmaceuticals Inc

Timber Pharmaceuticals Inc (TMBR)

0.3426
0.00
( 0.00% )
Updated: 19:00:00

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.3426
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.3426
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TMBR Latest News

Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American

WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and...

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to be Acquired by LEO Pharma

Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up to $36 millionTransaction Expected to...

Timber Pharmaceuticals Discloses Communication From NYSE American

WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis

- First Presentation of Data From Phase 3 ASCEND Study Will Feature Pharmacokinetic Results That Indicate Minimal Systemic Absorption of Isotretinoin - - Data to be Presented at the Society for...

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

- Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis is 70% enrolled - WARREN, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber...

Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results

- Timber has now Enrolled Over 60% of Patients for Pivotal TMB-001 Phase 3 ASCEND Clinical Trial - WARREN, NJ, May 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc...

Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results

- Lead asset TMB-001 is only compound to receive official orphan drug designation from European Commission for two severe subtypes of congenital ichthyosis, ARCI and XLRI - - Timber has enrolled...

Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

- Treatment with TMB-001 demonstrated greater proportions of participants achieving primary and key secondary endpoints versus vehicle regardless of the subtype of congenital ichthyosis - BASKING...

Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis

Company Progressing With Pivotal Phase 3 ASCEND Clinical Trial in the U.S., Canada, Italy, France, and Germany BASKING RIDGE, NJ, Feb. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

TMBR - Frequently Asked Questions (FAQ)

What is the current Timber Pharmaceuticals share price?
The current share price of Timber Pharmaceuticals is $ 0.3426
What is the 1 year trading range for Timber Pharmaceuticals share price?
Timber Pharmaceuticals has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KULRKULR Technology Group Inc
$ 4.485
(31.14%)
57.99M
RYDERyde Group Ltd
$ 0.3931
(26.81%)
18.86M
CTMCastellum Inc
$ 0.7347
(26.67%)
15.6M
OPTTOcean Power Technologies Inc
$ 0.406
(23.52%)
25.6M
ITPIT Tech Packaging Inc
$ 0.2649
(20.41%)
2.41M
BTOPBitwise Trendwise BTC ETH and Treasuries Rotation Strategy ETF
$ 35.0696
(-38.01%)
1.22k
BITCBitwise Trendwise Bitcoin and Treasuries Rotation Strategy ETF
$ 47.4401
(-29.88%)
11.69k
TOVXTheriva Biologics Inc
$ 1.50
(-14.77%)
527.41k
AETHBitwise Trendwise Ether and Treasuries Rotation Strategy ETF
$ 37.09
(-12.69%)
2.76k
GRFXGraphex Group Limited
$ 0.24
(-12.02%)
230.78k
KULRKULR Technology Group Inc
$ 4.5532
(33.13%)
58.29M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 1.9721
(-0.65%)
27.76M
OPTTOcean Power Technologies Inc
$ 0.40889
(24.40%)
26.21M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 30.81
(1.08%)
22.89M
RYDERyde Group Ltd
$ 0.40
(29.03%)
18.89M

Discussion

View Full Feed
SkyLimit2022 SkyLimit2022 4 minutes ago
zero82,

https://investorshub.advfn.com/uimage/uploads/2023/11/26/hwpzgIMG_6790.webp

Thanks for continually reposting your suggestion about how shareholders should proceed, but you are neither a qualified financial advisor nor an oncologist. 😶

Rath
NWBO
saigai saigai 4 minutes ago
i keep adding.. im right to..
BSLK
Lime Time Lime Time 4 minutes ago
35,110,000 .0001
177,200 .0003
BCAP
gdog gdog 5 minutes ago
12-26 B LEGN $ 32.87
Jack Torrance Jack Torrance 5 minutes ago
Highly doubt we get anything between now and the new year, Kona. Plus, it's not really IonQ's style to publish "teasers."
IONQ
mrfence mrfence 5 minutes ago
99.9995% on the way down. 35,000% on the way up.
FNMA
learningcurve2020 learningcurve2020 5 minutes ago
Maybe LP's looking at another property?? 
NWBO
powerbattles powerbattles 5 minutes ago
It's frustrating that all the due diligence we did on the company seems pointless when they’re dumping at these rock-bottom prices. Unfortunately, there's no way to predict when the dilution will stop. I’m still holding onto all my shares for now, and if the dilution does end, I'll consider doubling
AFFU
ReasearchThis ReasearchThis 5 minutes ago
Remember when 46 called everyone who was planning on
Voting 45 back again as 47, Garbage? AXXA has a lot of good
Investors, who do not like having their very good company "AXXA"
Called Garbage by a bunch of (my turn, trash) who have no idea how to run a company. Ninty nine perc
AXXA
FeMike FeMike 6 minutes ago
Anytime a company with no revenue can get 50 mill financing its not a bad thing.

It's no different from the $50 million they've already raised this year to keep the lights on.

Or the $50 million they raised last year.

It's selling shares to pay the bills.
NWBO
Jditi Jditi 6 minutes ago
IGTM: For hydrogen in the ira, they're tax credits, not "taxing us citizens and giving that (away)...". No investment = no tax credits. Investment = no handouts. Do you have a problem with companies investing in the future of the US?
PLUG
vein vein 6 minutes ago
Where do you see that transaction Rudd??? 
LWLG
Debunkinator Debunkinator 6 minutes ago
SOB's 🤬
ASII
manibiotech manibiotech 6 minutes ago
They will sell shares as usual to pay this off 
NWBO
Go Hawks13 Go Hawks13 6 minutes ago
Why am I an idiot? Everyone makes investment mistakes but blatantly putting false information on a board like you did in Fisker and also here is proving you are what you say I am.
FCEL
gdog gdog 6 minutes ago
and theres $17.58 shoulda waited lol
stock1ace1 stock1ace1 7 minutes ago
/PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, today announced that its Board of Directors has formed an independent Special Committee to explore strategic opportuniti
learningcurve2020 learningcurve2020 7 minutes ago
Have they made shareholders privy to those milestones? Don't recall reading about them. 
NWBO
TrendTrade2016 TrendTrade2016 7 minutes ago
QS READY TO BREAK 6.00
QS
10thMountain 10thMountain 7 minutes ago
HLLK Will go parabolic soon
HLLK
Theo Theo 7 minutes ago
Do we make $12 today?
ATOM
jaramill jaramill 7 minutes ago
$HHSE-NEWS:..Best-Selling Author Barr-McClellan Reveals-Campaign-Insights and Strategies for Trump Victory in 2024 Election

Click on URL below

https://www.einpresswire.com/article/771257686/best-selling-author-barr-mcclellan-reveals-campaign-insights-and-strategies-for
HHSE
threewheeler threewheeler 7 minutes ago
AZRH didnt expect much volume here until OTC Markets gets filings posted, but, should 8Ks hit with Button merger all bets off
AZRH

Your Recent History

Delayed Upgrade Clock